The blood-brain barrier efflux transporters as a detoxifying system for the brain

Advanced Drug Delivery Reviews

Volumn 36, Issue 2-3, 1999, Pages 195-209

  Terasaki, Tetsuya ^a   Hosoya, Ken Ichi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Brain efflux index method; Distributed model analysis; Efflux transport; Organic anions

Indexed keywords

ANTIBIOTICS; BLOOD; BRAIN; NEGATIVE IONS; NEUROPHYSIOLOGY; PHYSIOLOGICAL MODELS; PROTEINS;

BLOOD-BRAIN BARRIER; BRAIN EFFLUX INDEX METHOD; EFFLUX TRANSPORTERS;

CONTROLLED DRUG DELIVERY;

ANION; BLEOMYCIN; CYCLOSPORIN A; DOXORUBICIN; FLEROXACIN; GLYCOPROTEIN P; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VALSPODAR; VERAPAMIL; VINCRISTINE;

ANIMAL EXPERIMENT; BLOOD BRAIN BARRIER; DETOXIFICATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TRANSPORT; INTRAVENOUS DRUG ADMINISTRATION; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0033526186     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00088-X     Document Type: Review

References (70)

1. S.I. Rapoport, Blood-Brain Barrier in Physiology and Medicine, Raven Press, New York, 1976.
2. M.W. Bradbury, The Concept of a Blood-Brain Barrier, Wiley, Chichester, 1979.
3. H. Davson, History of the blood-brain barrier concept, in: E.A. Neuwelt (Ed.), Implications of the Blood-Brain Barrier and its Manipulation, Plenum Press, New York, 1989, pp. 27-52.
4. M.W. Brightman, The anatomic basis of the blood-brain barrier, in: E.A. Neuwelt (Ed.), Implications of the Blood-Brain Barrier and its Manipulation, Plenum Press, New York, 1989, pp. 53-84.
5. W.M. Pardridge, Peptide Drug Delivery to the Brain, Raven Press, New York, 1991.
6. Pardridge W.M. Vector-mediated peptide drug delivery to the brain. Adv. Drug Deliv. Rev. 15:1995;109-146.
7. Pardridge W.M. Transport of small molecules through the blood-brain barrier: biology and methodology. Adv. Drug Deliv. Rev. 15:1995;5-36.
8. W.M. Pardridge, The Blood-Brain Barrier: Cellular and Molecular Biology, Raven Press, New York, 1993.
9. Cornford E.M. The blood-brain barrier, a dynamic regulatory interface. Mol. Physiol. 7:1985;219-260.
10. Pardridge W.M., Triguero D., Yang J., Cancilla P.A. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J. Pharmacol. Exp. Ther. 253:1990;884-891.
11. Tsuji A., Terasaki T., Takabatake Y., Tenda Y., Tamai I., Yamashita T., Moritani S., Tsuruo T., Yamashita J. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 51:1992;1427-1437.
12. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A.A.M., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P.J., Berns A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
13. Tsuji A., Tamai I. Blood-brain barrier function of P-glycoprotein. Adv. Drug Deliv. Rev. 25:1997;287-298.
14. Levin V.A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23:1980;682-684.
15. Cordon-Cardo C., O'Brien J.P., Casals D., Rittaman-Grauer L., Biedler J.L., Melamed M.R., Bertino J.R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA. 86:1989;695-698.
16. Sugawara I., Hamada H., Tsuruo T., Mon S. Specialized localization of P-glycoprotein recognized by MRK16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn. J. Cancer Res. 81:1990;727-730.
17. Hamada H., Tsuruo T. Functional role for the 170 to 180 kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 83:1986;7785-7789.
18. Tatsuta T., Naito M., Oh-hara T., Sugawara I., Tsuruo T. Functional involvement of P-glycoprotein in blood-brain barrier. J. Biol. Chem. 267:1992;20383-20391.
19. Harashima H., Sawada Y., Sugiyama Y., Iga T., Hanano M. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics. J. Pharmacokinet. Biopharmacol. 13:1985;425-440.
20. Boesch D., Loor F. Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents. Anti-Cancer Drugs. 5:1994;229-238.
21. Kusuhara H., Suzuki H., Terasaki T., Kakee A., Lemaire M., Sugiyama Y. P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J. Pharmacol. Exp. Ther. 283:1997;574-580.
22. Levitan H., Ziylan Z., Smith Q.R., Takasato Y., Rapoport S.I. Brain uptake of a food dye, erythrosin B, prevented by plasma protein binding. Brain Res. 322:1984;131-134.
23. Hirohashi T., Terasaki T., Shigetoshi M., Sugiyama Y. In vivo and in vitro evidence for non-restricted transport of 2′,7′-bis(2-carboxy-ethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier. J. Pharmacol. Exp. Ther. 280:1997;813-819.
24. Conford E.M., Braun L.D., Oldendorf W.H., Hill M.A. Comparison of lipid-mediated blood-brain barrier penetrability in neonates and adults. Am. J. Physiol. 243:1982;C161-C168.
25. Cefalu W.T., Pardridge W.M. Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier. J. Neurochem. 45:1985;1954-1956.
26. Deguchi Y., Terasaki T., Kawasaki S., Tsuji A. Muscle microdialysis as a model study to relate the drug concentration in tissue interstitial fluid and dialysate. J. Pharmacobio-Dyn. 14:1991;483-492.
27. Deguchi Y., Terasaki T., Yamada H., Tsuji A. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of β-lactam antibiotics in interstitial fluids. J. Pharmacobio-Dyn. 15:1992;79-89.
28. Terasaki T., Deguchi Y., Kasama Y., Pardridge W.M., Tsuji A. Determination of in vivo steady-state unbound drug concentration in the brain interstitial fluid by microdialysis. Int. J. Pharm. 81:1992;143-152.
29. Jacobson I., Sandberg M., Hamberger A. Mass transfer in brain dialysis devices - a new method for the estimation of extracellular amino acids concentration. J. Neurosci. Methods. 15:1985;263-268.
30. Lonnroth P., Jansson P.A., Fredholm B.B., Smith U. Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans. Am. J. Physiol. 256:1989;E250-E255.
31. Lindefors N., Amberg G., Ungerstedt U. Intracerebral microdialysis. I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods. 22:1989;141-156.
32. Menacherry S., Hubert W., Justice J.B. In vivo calibration of microdialysis probes for exogenous compounds. Anal. Chem. 64:1992;577-583.
33. Jaehde U., Goto A.G., de Boer A.G., Breimer D.D. Blood-brain barrier transport rate quinolone antibacterials evaluated in cerebrovascular endothelial cell cultures. Eur. J. Pharm. Sci. 1:1993;49-55.
34. Okezaki E., Terasaki T., Nakamura M., Nagata O., Kato H., Tsuji A. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids. Drug Metab. Dispos. 16:1988;865-874.
35. Naora K., Katagiri Y., Ichikawa N., Hayashibara M., Iwamoto K. Enhanced entry of ciprofloxacin into the rat central nervous system induced by fenbufen. J. Pharmacol. Exp. Ther. 258:1991;1033-1037.
36. Ichikawa N., Naora K., Hayashibara M., Katagiri Y., Iwamoto K. Effect of fenbufen on the entry of new quinolon, nofloxacin and ofloxacin, into the central nervous system in rats. J. Pharm. Pharmacol. 44:1992;915-920.
37. Ooie T., Terasaki T., Suzuki H., Sugiyama Y. Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system. Drug Metab. Dispos. 25:1997;784-789.
38. Collins J.M., Dedrick R.L. Distributed model for drug delivery to CSF and brain tissue. Am. J. Physiol. 245:1983;R303-R310.
39. Ooie T., Terasaki T., Suzuki H., Sugiyama Y. Kinetic evidence for active transport at the blood-brain barrier of quinolone antibiotics. J. Pharmacol. Exp. Ther. 283:1997;293-304.
40. Takasawa K., Terasaki T., Suzuki H., Ooie T., Sugiyama Y. Distributed model analysis of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine distribution in brain tissue and CSF. J. Pharmacol. Exp. Ther. 282:1997;1509-1517.
41. Kakee A., Terasaki T., Sugiyama Y. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. J. Pharmacol. Exp. Ther. 277:1996;1550-1559.
42. Pardridge W.M., Boado R.J., Farrell C.R. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. J. Biol. Chem. 265:1990;18035-18040.
43. Farrell C.L., Yang J., Pardridge W.M. GLUT1 glucose transporter is present within apical and basolateral membranes of brain epithelial interface and in microvascular endothelia barriers with or without tight junction. J. Histochem. Cytochem. 40:1992;193-199.
44. Cornford E.M., Diep C.P., Pardridge W.M. Blood-brain barrier transport of valproic acid. J. Neurochem. 44:1985;1541-1550.
45. Terasaki T., Pardridge W.M. Restricted transport of 3′-azido-3′-deoxythymidine and dideoxynucleosides through the blood-brain barrier. J. Infect. Dis. 158:1988;630-632.
46. Suzuki H., Sawada Y., Sugiyama Y., Iga T., Hanano M. Facilitated transport of benzylpenicillin through the blood-brain barrier in rats. J. Pharmacobio-Dyn. 12:1989;182-185.
47. Adkison K.D., Artru A.A., Powers K.M., Shen D.D. Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system. J. Pharmacol. Exp. Ther. 268:1994;797-805.
48. Wang Y., Sawchuk R.J. Zidovudine transport in the rabbit brain during intravenous and intracerebroventricular infusion. J. Pharm. Sci. 84:1995;871-876.
49. Kanai N., Lu R., Bao Y., Wolkoff A.W., Schuster V.L. Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates. Am. J. Physiol. 270:1996;F319-325.
50. Kanai N., Lu R., Bao Y., Wolkoff A.W., Vore M., Schuster V.L. Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter. Am. J. Physiol. 270:1996;F326-331.
51. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am. J. Physiol. 272:1997;G16-G22.
52. Saito H., Masuda S., Inui K. Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J. Biol. Chem. 271:1996;20719-20725.
53. Angeletti R.H., Novikoff P.M., Juvvadi S.R., Fritschy J.M., Meier P.J., Wolkoff A.W. The choroid plexus epithelium is the site of the organic anion transport protein in the brain. Proc. Natl. Acad. Sci. USA. 94:1997;283-286.
54. Noé B., Hagenbuch B., Stieger B., Meier P.J. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc. Natl. Acad. Sci. USA. 94:1997;10346-10350.
55. Fitzgibbon M., FitzGerald R.J., Tormey W.P., O'Meara A., Kenny D. Reference values for urinary HMMA, HVA, noradrenaline, adrenaline, and dopamine excretion in children using random urine samples and HPLC with electrochemical detection. Anal. Clin. Biochem. 29:1992;400-404.
56. Pritchard J.B. Luminal and peritubular steps in renal transport of p-aminohippurate. Biochim. Biophys. Acta. 906:1987;295-308.
57. Takano M., Hirozane K., Okamura M., Takayama A., Nagai J., Hori R. p-Aminohippurate transport in apical and basolateral membranes of the OK kidney epithelial cells. J. Pharmacol. Exp. Ther. 269:1994;970-975.
58. Sekine T., Watanabe N., Hosoyamada M., Kanai Y., Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J. Biol. Chem. 272:1997;18526-18529.
59. Holloway L.S., Cassin S. In vitro uptake of PAH-3H by choroid plexus from dogs of various ages. Am. J. Physiol. 223:1972;507-509.
60. Domer F.R. Drug inhibition of PAH transport from cerebrospinal fluid in rabbits. Exp. Neurol. 40:1973;414-423.
61. Kakee A., Terasaki T., Sugiyama Y. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method. J. Pharmacol. Exp. Ther. 283:1997;1018-1025.
62. Takasawa K., Terasaki T., Suzuki H., Sugiyama Y. In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J. Pharmacol. Exp. Ther. 281:1997;369-375.
63. Kitazawa T., Terasaki T., Suzuki H., Kakee A., Sugiyama Y. Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides. J. Pharmacol. Exp. Ther. 286:1998;890-895.
64. Meier P.J. Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am. J. Physiol. 269:1995;G801-812.
65. H. Asaba, K. Hosoya, T. Terasaki, Efflux transport of estron sulfate at blood-brain barrier: in vivo evidence by the use of brain efflux index method, in: Conference on Challenges for Drug Delivery and Pharmaceutical Technology, Tokyo, 1998, p. 92.
66. Borthwick E.B., Burchell A., Coughtrie M.W.H. Purification and immunochemical characterization of male-specific rat liver estrogen sulphotransferase. Biochem. J. 289:1993;719-725.
67. T. Terasaki, K. Hosoya, The brain efflux index method, (BEI), in: Proceedings of 45th Alfred Benzon Symposium, Copenhagen (in press).
68. K. Hosoya, M. Sugawara, T. Terasaki, Stereoselective efflux transport of acidic amino acids at the blood-brain barrier: in vivo evidence by the use of brain efflux index method, in: Conference on Challenges for Drug Delivery and Pharmaceutical Technology, Tokyo, 1998, p. 91.
69. Huai-Yun H., Secrest D.T., Mark K.S., Carney D., Brandquist C., Elmquist W.F., Miller D.W. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem. Biophys. Res. Commun. 243:1998;816-820.
70. Seetharaman S., Barrand M.A., Maskell L., Scheper R.J. Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolated. J. Neurochem. 70:1998;1151-1159.